ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 147 filers reported holding ASCENDIS PHARMA A/S in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $8,208,000 | +15.3% | 55,500 | -12.2% | 2.37% | -31.3% |
| Q1 2020 | $7,117,000 | +127.4% | 63,200 | +180.9% | 3.45% | +345.2% |
| Q4 2019 | $3,130,000 | -38.2% | 22,500 | -68.5% | 0.78% | -57.1% |
| Q3 2018 | $5,066,000 | -75.5% | 71,500 | -77.0% | 1.81% | -51.0% |
| Q2 2018 | $20,695,000 | -41.8% | 311,111 | -42.8% | 3.68% | -36.6% |
| Q1 2018 | $35,578,000 | +67.3% | 544,000 | +2.4% | 5.81% | +44.7% |
| Q4 2017 | $21,272,000 | +17.4% | 531,000 | +6.2% | 4.02% | +23.6% |
| Q3 2017 | $18,125,000 | -29.4% | 500,000 | -45.9% | 3.25% | -54.8% |
| Q2 2017 | $25,664,000 | +66.6% | 924,483 | +68.1% | 7.18% | +96.7% |
| Q1 2017 | $15,400,000 | +32.3% | 550,000 | -4.4% | 3.65% | -15.7% |
| Q4 2016 | $11,644,000 | +59.6% | 575,309 | +58.5% | 4.33% | +58.1% |
| Q3 2016 | $7,296,000 | +16.3% | 363,000 | -23.2% | 2.74% | -9.2% |
| Q2 2016 | $6,274,000 | -45.8% | 472,800 | -24.2% | 3.02% | -53.4% |
| Q1 2016 | $11,568,000 | +21.6% | 623,631 | +20.1% | 6.47% | +42.2% |
| Q4 2015 | $9,513,000 | +14.4% | 519,243 | +10.5% | 4.55% | -5.5% |
| Q3 2015 | $8,317,000 | +11.5% | 469,893 | +11.4% | 4.82% | +4.4% |
| Q2 2015 | $7,458,000 | +88.0% | 421,851 | +84.5% | 4.61% | +38.1% |
| Q1 2015 | $3,966,000 | – | 228,612 | – | 3.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |